Explore
Trendline
Caris Life Sciences Reports Significant Revenue Growth in First Quarter 2026
Caris Life Sciences Reports Significant Revenue Growth in First Quarter 2026
Read More
Trendline
Zai Lab Reports Q1 2026 Financial Results and Advances Oncology Pipeline
Zai Lab Reports Q1 2026 Financial Results and Advances Oncology Pipeline
Read More
Trendline
EyePoint Reports Q1 2026 Financial Results, Highlights Progress in Retinal Disease Trials
EyePoint Reports Q1 2026 Financial Results, Highlights Progress in Retinal Disease Trials
Read More
Trendline
AtriCure Reports Strong Q1 2026 Financial Results with 14.3% Revenue Growth
AtriCure Reports Strong Q1 2026 Financial Results with 14.3% Revenue Growth
Read More
Trendline
IonQ Reports Record Q1 2026 Revenue, Raises Full-Year Guidance
IonQ Reports Record Q1 2026 Revenue, Raises Full-Year Guidance
Read More
Trendline
Quantum-Si Announces First Quarter 2026 Financial Results and Proteus Development Milestones
Quantum-Si Announces First Quarter 2026 Financial Results and Proteus Development Milestones
Read More
Trendline
Charles River Laboratories Reports Q1 2026 Revenue Growth Amid Divestitures
Charles River Laboratories Reports Q1 2026 Revenue Growth Amid Divestitures
Read More
Trendline
EyePoint Pharmaceuticals Reports Q1 2026 Financial Results Amid Clinical Progress
EyePoint Pharmaceuticals Reports Q1 2026 Financial Results Amid Clinical Progress
Read More
Trendline
Personalis Secures Medicare Coverage for Lung Cancer, Reports Q1 Financial Results
Personalis Secures Medicare Coverage for Lung Cancer, Reports Q1 Financial Results
Read More
Trendline
GeneDx Reports Q1 2026 Financial Results and Updates Outlook
GeneDx Reports Q1 2026 Financial Results and Updates Outlook
Read More
Trendline
Vanda Pharmaceuticals Reports Q1 2026 Financial Results Highlighting Growth and New Product Launches
Vanda Pharmaceuticals Reports Q1 2026 Financial Results Highlighting Growth and New Product Launches
Read More
Trendline
Personalized Medicine Market Projected to Reach USD 1,397.63 Billion by 2035 Due to Genomic Advancements
Personalized Medicine Market Projected to Reach USD 1,397.63 Billion by 2035 Due to Genomic Advancements
Read More
